Effects of chlorpromazine and propranolol on in vitro thyroid activation by thyrotropin, long-acting thyroid stimulator and dibutyryl cyclic-AMP.
D000227:Adenine Nucleotides / Q000037:antagonists & inhibitors*; D000818:Animals; D002746:Chlorpromazine / Q000494:pharmacology*; D000242:Cyclic AMP / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004285:Dogs; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D008135:Long-Acting Thyroid Stimulator / Q000037:antagonists & inhibitors*; D008247:Lysosomes / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects*; D010743:Phospholipids / Q000096:biosynthesis; D010759:Phosphorus Isotopes; D011433:Propranolol / Q000494:pharmacology*; D013954:Thyroglobulin / Q000378:metabolism; D013961:Thyroid Gland / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D013972:Thyrotropin / Q000037:antagonists & inhibitors*
D000227:Adenine Nucleotides; D010743:Phospholipids; D010759:Phosphorus Isotopes; D013972:Thyrotropin; D013954:Thyroglobulin; D008135:Long-Acting Thyroid Stimulator; D011433:Propranolol; D000242:Cyclic AMP; D005947:Glucose; D002746:Chlorpromazine